Evidence map›Paper›PMID 24186909›Full record

ArticleNeurology2013

Neurology residency program as factor associated with thrombolysis utilization in acute stroke.

Svetlana Lorenzano

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Svetlana LorenzanoFrom the Emergency Department Stroke Unit, Department of Neurology and Psychiatry, Policlinico Umberto I Hospital, Sapienza University of Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite strong evidence on the safety and efficacy of IV alteplase up to 4.5 hours after ischemic stroke (IS) symptom onset and increased use of thrombolysis over recent decades, this treatment remains underused and accessible to only a fraction of patients. The rate of thrombolysis in the United States is 3.4%-5.2% of all stroke cases. Several studies have identified barriers to thrombolysis delivery, but other as yet unmeasured factors may also underlie these barriers, thereby influencing rates of thrombolysis utilization and access.

Indexed as

HospitalsInternship and ResidencyBrain IschemiaFemaleHumansMaleNeurologyStrokeThrombolytic Therapy

Identifiers

PMID24186909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.